Researchers have been excited about the medication , a novel dual agonist showing remarkable data in initial trials for size loss . It acts by impacting both hormones : GLP-1 and GIP, that , when https://poppycaoy282792.bloguetechno.com/a-new-prospect-for-size-reduction-77274994